EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Variable transduction of thyroid hormone signaling in structures of the mouse brain

Richárd Sinkó iD, Federico Salas-Lucia iD, Petra Mohácsik iD, Emese Halmos, Gábor Wittmann, Péter Egri, Barbara M L C Bocco, Alice Batistuzzo iD, Tatiana L Fonseca iD, Csaba Fekete iD, Antonio C Bianco iD, Balázs Gereben iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2415970122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Richárd Sinkó und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Cell Metabolism, HUN-REN Institute of Experimental Medicine, Budapest 1083, Hungary. Hauptthemen laut MEDLINE: Signal Transduction, Thyroxine, Brain, Thyroid Hormones. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIDDK NIH HHS, National Research, Development and Innovation Office Hungary.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

L-thyroxine (L-T4) monotherapy is the standard treatment for hypothyroidism, administered daily to normalize TSH levels. Once absorbed, T4 is converted to T3 to alleviate most symptoms. However, this treatment abnormally elevates plasma T4 levels in over 50% of patients. Using L-T4-treated Thyroid Hormone (TH) Action Indicator mice, which express a T3-regulated luciferase (Luc) reporter, we examined whether these T4 elevations disrupt TH signaling. Hypothyroid mice exhibited reduced Luc expression across brain regions, and L-T4 treatment failed to restore T3 signaling uniformly. There was also variability in the activity of type 2 deiodinase (D2), the enzyme that generates most brain T3. Intracerebroventricular T4 administration achieved higher elevation of Luc expression in the mediobasal hypothalamus compared to the cortex, and studies on cultured cortical astrocytes and hypothalamic tanycytes revealed cell-type-specific responses to T4. In tanycytes, exposure to T4 sustained D2 activity, leading to progressive T3 signaling, whereas in astrocytes, T4 exposure triggered a drop in D2 activity, limiting T3 production through a ubiquitin-dependent, self-limiting mechanism. The sustained D2 activity in tanycytes was linked to rapid deubiquitination by USP33, as confirmed using a ubiquitin-specific protease (USP) pan-inhibitor and USP33 knockout mice. In conclusion, the brain’s response to L-T4 treatment is heterogeneous, influenced by cell-specific regulation of D2-mediated T3 production. While cortical astrocytes exhibit limited T3 signaling due to D2 ubiquitination, tanycytes coexpressing USP33 amplify T3 signaling by rescuing ubiquitinated D2 from proteasomal degradation. These findings provide mechanistic insights into the limitations of L-T4 therapy and highlight the need for tailored approaches to managing hypothyroidism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionThyroxineBrainThyroid HormonesAnimalsMiceIodide PeroxidaseAstrocytesTriiodothyronineHypothyroidismIodothyronine Deiodinase Type IIMaleEpendymoglial CellsMice, Inbred C57BL

Stichwörter der Autor:innen

L-T4 supplementationbraindeiodinasehypothyroidismthyroid hormone

Substanzen

ThyroxineIodide PeroxidaseThyroid HormonesTriiodothyronineIodothyronine Deiodinase Type II

Autor:innen und Institutionen

  • Laboratory of Molecular Cell Metabolism, HUN-REN Institute of Experimental Medicine, Budapest 1083, Hungary.
  • Section of Adult and Pediatric Endocrinology and Metabolism, University of Chicago, Chicago, IL IL60637.
  • János Szentágothai Neurosciences Division, Doctoral College, Semmelweis University, Budapest 1085, Hungary.
  • Laboratory of Integrative Neuroendocrinology, HUN-REN Institute of Experimental Medicine, Budapest 1083, Hungary.

ORCID-Profile: Richárd Sinkó, Federico Salas-Lucia, Petra Mohácsik, Alice Batistuzzo, Tatiana L Fonseca, Csaba Fekete, Antonio C Bianco, Balázs Gereben

Förderung

  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • NIDDK NIH HHS
  • National Research, Development and Innovation Office Hungary

Zitieren

APA

Sinkó, R., Salas-Lucia, F., Mohácsik, P., Halmos, E., Wittmann, G., Egri, P., Bocco, B. M. L. C., Batistuzzo, A., Fonseca, T. L., Fekete, C., Bianco, A. C., & Gereben, B. (2025). Variable transduction of thyroid hormone signaling in structures of the mouse brain. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2415970122

Vancouver

Sinkó R, Salas-Lucia F, Mohácsik P, Halmos E, Wittmann G, Egri P, et al. Variable transduction of thyroid hormone signaling in structures of the mouse brain. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2415970122

BibTeX
@article{Sink2025,
  author = {Sinkó, Richárd and Salas-Lucia, Federico and Mohácsik, Petra and Halmos, Emese and Wittmann, Gábor and Egri, Péter and Bocco, Barbara M L C and Batistuzzo, Alice and Fonseca, Tatiana L and Fekete, Csaba and Bianco, Antonio C and Gereben, Balázs},
  title = {Variable transduction of thyroid hormone signaling in structures of the mouse brain},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2415970122}
}
Kostenlos starten →